Selexis SA

At Stämm we develop accessible, plug & play biomanufacture solutions; allowing an automatized, continuous and more efficient production of biologics and cell therapies while managing media conditions. We have reinvented biomanufacturing by providing an alternative to the known biomass production.

Quant Biomarkers AG, a Swiss life sciences technology company, specializes in predictive biomarker-based platforms for early detection of chronic disease risk and new therapeutic targets. Leveraging innovations in AI/ML & novel biomarkers, we address healthcare challenges in aging populations.

At EY, we are proud to be driven by our purpose to build a better working world, helping to create long-term value for our clients, people, and communities. As a trusted partner, we leverage our experience, knowledge, and services around the world.